NCT00103714View on ClinicalTrials.gov

Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Cystic Fibrosis
Interventions
DRUG

denufosol tetrasodium (INS37217)

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00103714 - Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease | Biotech Hunter | Biotech Hunter